Dr. Mark Slaughter, MD
Claim this profileJewish Hospital
Studies Atrial Fibrillation
Studies Aortic Valve Stenosis
4 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Mark Slaughter, MD is currently running
TAVR
for Aortic Stenosis
Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.
Recruiting1 award N/A3 criteria
Left Atrial Appendage Exclusion
for Stroke Prevention
This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.
Recruiting1 award N/A2 criteria
More about Mark Slaughter, MD
Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Mark Slaughter, MD has experience with
- Amiodarone-Infused CardiaMend Patches
- Evolut FX TAVR System
- Medtronic Evolut PRO+ TAVR System
- EVAHEART®2 Left Ventricular Assist System
- HeartMate 3
- AtriClip LAA Exclusion System
Breakdown of trials Mark Slaughter, MD has run
Atrial Fibrillation
Aortic Valve Stenosis
Heart Failure
Retinal Embolism Thrombosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Slaughter, MD specialize in?
Mark Slaughter, MD focuses on Atrial Fibrillation and Aortic Valve Stenosis. In particular, much of their work with Atrial Fibrillation has involved treating patients, or patients who are undergoing treatment.
Is Mark Slaughter, MD currently recruiting for clinical trials?
Yes, Mark Slaughter, MD is currently recruiting for 3 clinical trials in Louisville Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Mark Slaughter, MD has studied deeply?
Yes, Mark Slaughter, MD has studied treatments such as Amiodarone-Infused CardiaMend Patches, Evolut FX TAVR System, Medtronic Evolut PRO+ TAVR System.
What is the best way to schedule an appointment with Mark Slaughter, MD?
Apply for one of the trials that Mark Slaughter, MD is conducting.
What is the office address of Mark Slaughter, MD?
The office of Mark Slaughter, MD is located at: Jewish Hospital, Louisville, Kentucky 40202 United States. This is the address for their practice at the Jewish Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.